Abstract

An effective ultra-performance liquid chromatography coupled with the quadrupole time-of-flight tandem mass spectrometry (UPLC/Q-TOF/MS) method was developed for analysing the chemical constituents in rat plasma and urine after the oral administration of Rubia cordifolia L. extract. Under the optimized conditions, nine of 11 prototypes in rat plasma and four prototypes in urine were identified or characterized by comparing the retention time, accurate mass, fragmentation patterns, reference compounds, and literature data. In total, six metabolites, including alizarin-1-O-β-glucuronide, alizarin-2-O-β-glucuronide, alizarin-1-O-sulfation, alizarin-2-O-sulfation, purpurin-1-O-β-glucuronide, and purpurin-3-O-β-glucuronide, were identified in rat plasma, which were confirmed by lavaging standard solutions. Purpurin was found to be able to be transformed into alizarin based on the results in which alizarin was detected in rat plasma after the oral administration of a purpurin solution. In total, four metabolites were found in rat urine, but their chemical structures were not confirmed. The results indicate that the metabolic pathway of alizarin involves glucuronidation and sulfation, with the purpurins having undergone glucuronidation. The components absorbed into the blood, and the metabolites have the opportunity to become bioactive constituents. The experimental results would supply a helpful chemical basis for further research on the mechanism of actions of Rubia cordifolia L.

Highlights

  • Rubia cordifolia L. was officially listed in the 2015 edition of the Chinese Pharmacopoeia and is widely used as a traditional Chinese medicine for the treatment of tuberculosis, contusions, menoxenia, and rheumatism in China, Japan, Korea, and India [1]

  • Nine prototype components and six metabolites including alizarin-1-O-β-glucuronide, alizarin-2-O-β-glucuronide, alizarin-1-O-sulfation, alizarin-2-O-sulfation, purpurin-1-O-β-glucuronide, and purpurin-3-O-β-glucuronide were identified in the plasma

  • This indicates that the metabolic pathway of alizarin involves glucuronidation and sulfation, with the purpurins having undergone glucuronidation

Read more

Summary

Introduction

Rubia cordifolia L. was officially listed in the 2015 edition of the Chinese Pharmacopoeia and is widely used as a traditional Chinese medicine for the treatment of tuberculosis, contusions, menoxenia, and rheumatism in China, Japan, Korea, and India [1]. It is difficult to identify them due to interference from endogenous metabolites, their extremely low concentrations [17], a lack of standards, and diverse structure types. Their many isomers further increased the difficulty of the analysis and the uncertainty of the results. A UPLC/Q-TOF-MS method was developed to systematically analyze the prototypes and metabolites in rat plasma and urine after oral administration of Rubia cordifolia L. for revealing the metabolic pathways and understanding the mechanism of action of Rubia cordifolia L

Results and Discussion
80 Da larger than
Metabolic
11 It could be OH wereGlc
80 Da more than the precursor compound
Materials and Methods
Instrument
Biological Sample Preparation
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call